Prevalence of albuminuria in Australia: The AusDiab Kidney Study

This publication has 12 references indexed in Scilit:

• The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates
  Diabetes Research and Clinical Practice, 2002
• The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
  New England Journal of Medicine, 2001
• Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
  New England Journal of Medicine, 2001
• Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease
  Annals of Internal Medicine, 2001
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993
• Eight to nine year mortality in known non-insulin dependent diabetics and controls
  Kidney International, 1992
• Microalbuminuria as predictor of increased mortality in elderly people.
  BMJ, 1990
• MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
  The Lancet, 1988
• Microalbuminuria as a predictor of clinical diabetic nephropathy
  Kidney International, 1987
• Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
  New England Journal of Medicine, 1984